We are live on
!
Find out more
ICM
Invenomic Capital Management Portfolio holdings
AUM
$2.18B
1-Year Est. Return
0.03%
This Fund
S&P 500
This Quarter
Est. Return
+14.24%
1 Year Est. Return
+0.03%
3 Year Est. Return
-6.37%
5 Year Est. Return
-25.27%
10 Year Est. Return
–
AUM
$2.19B
AUM Growth
-$189M
(-7.9%)
Cap. Flow
-$471M
Cap. Flow
% of AUM
-21.5%
Top 10 Holdings %
Top 10 Hldgs %
25.76%
Holding
204
New
59
Increased
25
Reduced
88
Closed
32
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SolarEdge
SEDG
|
+$41.5M |
| 2 |
Illumina
ILMN
|
+$40.9M |
| 3 |
QuidelOrtho
QDEL
|
+$34.1M |
| 4 |
CIVI
Civitas Resources
CIVI
|
+$18.5M |
| 5 |
FMC
FMC
|
+$17.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$245M |
| 2 |
Apple
AAPL
|
+$85.6M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$56.2M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$40.7M |
| 5 |
Corpay
CPAY
|
+$40.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.91% |
| 2 | Consumer Discretionary | 12.94% |
| 3 | Healthcare | 12.41% |
| 4 | Communication Services | 8.9% |
| 5 | Industrials | 7.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Iovance Biotherapeutics
IOVA
$2.9B
| $8.56M | 0.39% |
+1,053,251
| New | +$5.51M |
|
77
Advance Auto Parts
AAP
$3.36B
| $8.54M | 0.39% |
140,008
+110,410
| +373% | +$6.05M |
|
78
Equinox Gold
EQX
$13.5B
| $8.35M | 0.38% |
1,706,659
+342,695
| +25% | +$1.63M |
|
79
Alight
ALIT
$394M
| $8.27M | 0.38% |
48,457
-22,419
| -32% | -$3.31M |
|
80
Sally Beauty Holdings
SBH
$1.57B
| $8.26M | 0.38% |
+621,825
| New | +$6.02M |
|
81
Mativ Holdings
MATV
$706M
| $8.17M | 0.37% |
533,610
+20,938
| +4% | +$283K |
|
82
American Electric Power
AEP
$66.9B
| $8.03M | 0.37% |
+98,849
| New | +$7.67M |
|
83
8x8 Inc
EGHT
$324M
| $7.85M | 0.36% |
2,077,777
+990,352
| +91% | +$2.94M |
|
84
Alibaba
BABA
$317B
| $7.77M | 0.35% |
+100,240
| New | +$7.99M |
|
|
B
85
DELISTED
Barnes Group Inc.
B
| $7.76M | 0.35% |
+237,777
| New | +$6.79M |
|
|
FARO
86
DELISTED
Faro Technologies
FARO
| $7.67M | 0.35% |
340,242
-214,003
| -39% | -$3.67M |
|
87
Newell Brands
NWL
$2.51B
| $7.53M | 0.34% |
867,247
-789,284
| -48% | -$6.02M |
|
88
Tandem Diabetes Care
TNDM
$1.59B
| $7.13M | 0.33% |
241,006
-31,438
| -12% | -$652K |
|
|
SEE
89
DELISTED
Sealed Air
SEE
| $6.83M | 0.31% |
+187,142
| New | +$6.14M |
|
90
Universal Health Services
UHS
$10.5B
| $6.79M | 0.31% |
44,523
-74,651
| -63% | -$10M |
|
91
NovoCure
NVCR
$2.02B
| $6.48M | 0.3% |
+433,951
| New | +$5.81M |
|
|
HRT
92
DELISTED
HireRight Holdings Corporation
HRT
| $6.22M | 0.28% |
462,762
-350,699
| -43% | -$3.97M |
|
|
WBA
93
DELISTED
Walgreens Boots Alliance
WBA
| $6.21M | 0.28% |
237,663
-216,482
| -48% | -$4.84M |
|
94
Upwork
UPWK
$1.21B
| $6.17M | 0.28% |
414,908
-799,321
| -66% | -$10.3M |
|
|
PARA
95
DELISTED
Paramount Global Class B
PARA
| $6.11M | 0.28% |
413,168
+245,427
| +146% | +$3.29M |
|
|
ALE
96
DELISTED
Allete
ALE
| $6.03M | 0.28% |
98,601
-22,386
| -19% | -$1.26M |
|
|
OPLN
97
Openlane
OPLN
$4.58B
| $6.01M | 0.27% |
+405,727
| New | +$5.9M |
|
98
Mistras Group
MG
$502M
| $6M | 0.27% |
819,491
-144,286
| -15% | -$886K |
|
99
Mohawk Industries
MHK
$9.19B
| $5.91M | 0.27% |
+57,064
| New | +$5M |
|
100
The GEO Group
GEO
$4.04B
| $5.9M | 0.27% |
545,194
-455,474
| -46% | -$4.35M |
|
Similar funds
SIG
ORCP
ET
GC
MIAS
TAL
IIP
WCMNY
Invenomic Capital Management's Q4 2023 Portfolio in Review
As of Q4 2023, Invenomic Capital Management held 204 positions worth $2.19B, down 7.9% from $2.38B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Invenomic Capital Management withdrew a net $471M in Q4 2023, closing 32 positions and reducing 88 holdings. Its most notable exit was State Street SPDR S&P 500 ETF Trust, an estimated $245M position sold in full.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 23% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Invenomic Capital Management opened a new position in SolarEdge worth $42.6M.
- Invenomic Capital Management's largest Q4 2023 buy was SolarEdge: 455,600 shares worth $42.6M.
- Invenomic Capital Management added most to IPG Photonics in Q4 2023, an estimated $11.6M increase.
- Invenomic Capital Management's biggest Q4 2023 reduction was Corpay, cutting an estimated $40.2M.
- Invenomic Capital Management fully exited State Street SPDR S&P 500 ETF Trust in Q4 2023, selling an estimated $245M.
- Invenomic Capital Management's ten largest holdings make up 26% of its $2.19B portfolio in Q4 2023.
- Invenomic Capital Management opened 59 new positions and closed 32 in Q4 2023.
- Invenomic Capital Management's portfolio value fell 7.9% quarter-over-quarter to $2.19B.
Based on Invenomic Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.